The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine/docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish Group of Sarcoma Investigation (GEIS).
 
Jaume Mora
No Relationships to Disclose
 
Alicia Castaneda
No Relationships to Disclose
 
Essy Madariegue
No Relationships to Disclose
 
Antonio Lopez-Pousa
No Relationships to Disclose
 
Claudia María Valverde
No Relationships to Disclose
 
Javier Martin Broto
Consulting or Advisory Role - Amgen; Bayer; GlaxoSmithKline; Novartis; PharmaMar
Speakers' Bureau - PharmaMar
Research Funding - GlaxoSmithKline; PharmaMar
Expert Testimony - Novartis; PharmaMar
Travel, Accommodations, Expenses - Pfizer; PharmaMar
 
Xavier Garcia del Muro
Consulting or Advisory Role - Bayer; Pfizer
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Javier Martinez Trufero
No Relationships to Disclose
 
Josefina Cruz
No Relationships to Disclose
 
Joan Maurel
No Relationships to Disclose
 
Maria Angeles Vaz
No Relationships to Disclose
 
Sara Perez-Jaume
No Relationships to Disclose
 
Enrique Alava
No Relationships to Disclose
 
Carmen de Torres
No Relationships to Disclose